Glenmark Pharmaceuticals informs about media release

03 Jan 2024 Evaluate

Glenmark Pharmaceuticals has informed that it enclosed media release titled ‘Glenmark is the first to launch Biosimilar of Popular Anti?Diabetic Drug, Liraglutide, in India’.

The above information is a part of company’s filings submitted to BSE.

Glenmark Pharma Share Price

1054.25 -17.40 (-1.62%)
30-Apr-2024 16:01 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1502.30
Dr. Reddys Lab 6198.90
Cipla 1402.20
Zydus Lifesciences 957.00
Lupin 1645.00
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt.Ltd.